^
BIOMARKER:
EGFR overexpression
i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR overexpression
Esophageal Squamous Cell Carcinoma
erlotinib
Sensitive
:
B
EGFR overexpression
NSCLC
necitumumab
Sensitive
:
C2
EGFR overexpression
SCCHN
cetuximab
Sensitive
:
C2
EGFR overexpression
NSCLC
gefitinib
Sensitive
:
C2
EGFR overexpression
Gastric Cancer
ASLAN001
Sensitive
:
C3
EGFR overexpression
CRC
cetuximab
Sensitive
:
C3
EGFR overexpression
Gastric Cancer
GC-1118A
Sensitive
:
C3
EGFR overexpression
LUAD
Tyrosine kinase inhibitor
Sensitive
:
C3
EGFR overexpression
CRC
EGFR inhibitor
Resistant
:
C3
EGFR overexpression
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
C4
EGFR overexpression
Osteosarcoma
gemcitabine
Resistant
:
D
EGFR overexpression
Triple Negative Breast Cancer
ABT 263 + ABBV-321
Sensitive
:
D
EGFR overexpression
Triple Negative Breast Cancer
ABT 263 + ABT-414
Sensitive
:
D
EGFR overexpression
GBM
ONC201
Resistant
:
D
EGFR overexpression
Lung Cancer
cetuximab + avelumab
Sensitive
:
D
EGFR overexpression
Gastric Cancer
cetuximab
Sensitive
:
D
EGFR overexpression
NSCLC
cetuximab
Sensitive
:
D
EGFR overexpression
Breast Cancer
vandetanib
Sensitive
:
D
EGFR overexpression
Esophageal Squamous Cell Carcinoma
nimotuzumab
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our